Signal active
Organization
Contact Information
Overview
Sphere Fluidics Limited is a new Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.
About
Biotechnology, Life Science, Pharmaceutical
2010
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
Sphere Fluidics headquartered in Europe, operates in the Biotechnology, Life Science, Pharmaceutical sector. The company focuses on Biotechnology and has secured $6.6B in funding across 108 round(s). With a team of 51-100 employees, Sphere Fluidics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Sphere Fluidics, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
9
4
0
$61.2M
Details
4
Sphere Fluidics has raised a total of $61.2M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2012 | Seed | |||
2017 | Late Stage Venture | |||
2014 | Early Stage Venture | 2.4M | ||
2013 | Early Stage Venture | 2.5M |
Investors
Sphere Fluidics is funded by 29 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
QVentures | - | FUNDING ROUND - QVentures | 2.4M |
Cambridge Angels group | - | FUNDING ROUND - Cambridge Angels group | 2.5M |
Sphere Fluidics | - | FUNDING ROUND - Sphere Fluidics | 2.5M |
Amadeus Capital Partners | - | FUNDING ROUND - Amadeus Capital Partners | 2.5M |
Recent Activity
There is no recent news or activity for this profile.